Protalix BioTherapeutics Inc.

XASE:PLX

2.09

+0.04 (+1.95%)

6:03:29 PM EDT: $2.10 +0.01 (+0.39%)

Market Cap (Intraday)	171.68M
Current PE	11.20
Forward PE	10.45
2yr Forward PE	41.8

See more stats

Estimates Current Quarter

Revenue	$12.95 Million
Adjusted EPS	-$0.01

See more estimates

10-Day MA	N/A
50-Day MA	N/A
200-Day MA	N/A

See more pivots

Protalix BioTherapeutics Inc. Stock, XASE:PLX

2 University Plaza, Suite 100, Hackensack, New Jersey 07601

United States of America

Phone: +1.201.696.9345

Number of Employees: 213

http://www.protalix.com

Description

Protalix Biotherapeutics, Inc. is a biopharmaceutical company, which engages in the development, production, and commercialization of recombinant therapeutic proteins based on plant cell based expression system. Its products include Alidornase alfa, PRX-115 and PRX-11. The company was by Yoseph Shaaltiel in 1993 and is headquartered in Hackensack, NJ.